Revolutionizing Healthcare: miDiagnostics Secures $30 Million in Funding for Miniaturized Lab-Quality Tests

We are thrilled to announce that miDiagnostics has successfully raised €30 million in its latest funding round, a significant milestone that propels our mission to revolutionize health diagnostics. Founded in 2015 and emerging from the renowned R&D hub imec, in collaboration with the prestigious Johns Hopkins University, miDiagnostics is at the forefront of innovation in the medical technology landscape. Our cutting-edge silicon chip technology enables the development of miniaturized, rapid, and user-friendly lab-quality tests, empowering both patients and clinicians with immediate access to vital health information. This funding will enable us to expand our extensive portfolio of tests, which targets a diverse range of health conditions, particularly infectious diseases, by integrating our advanced nanofluidic processor and compact reader. By harnessing built-in connectivity, we aim to facilitate seamless health analyses that are not only comprehensive but also cost-effective. As a privately held company based in Leuven, Belgium, this capital infusion will help us accelerate product development and expand our operational reach, ultimately allowing us to bring our transformative diagnostic solutions directly to diverse patient populations. We are excited to embark on this next phase of growth and innovation, which will significantly enhance health assessments across various settings, regardless of geographic limitations. Our commitment to delivering faster, more accessible diagnostic solutions aligns with the evolving needs of healthcare today—paving the way for a future where timely health interventions are available to everyone, everywhere.